Daily BriefsUnited States

Daily Brief United States: Intel Corp, Crude Oil, Natural Gas, S&P 500 INDEX, Gold, Mira Pharmaceuticals , Longeveron , Titan International , VAALCO Energy, Windtree Therapeutics and more

In today’s briefing:

  • Former CEO Claims Intel Is Back & Says Can We Please Stop Talking About Breaking It Up?
  • [US Crude Oil Options Weekly 2025/09] WTI Fell for Sixth Week on Trade Tensions and Demand Worries
  • [US Nat Gas Options Weekly 2025/09] Henry Hub Falls on Milder Weather and Weaker Demand Outlook
  • S&P 500 and Nasdaq 100 Testing Initial Support; Russell and Nasdaq With Bullish Breadth Divergences
  • [Precious Insights 2025/09] Gold Miners Surge Amid Market Volatility, Protective Pisitioning Builds
  • MIRA: Critical Testing Approved
  • LGVN: Great Position for Pivotal Year
  • TWI: Titan reports 4th quarter and full year 2024 financial and operating results. The company also commented on recovery in its markets as well as the possible effects of tariffs.
  • Vaalco Energy (NYSE: EGY): Adding exploration upside in Cote d’Ivoire
  • Windtree Therapeutics Inc – Sponsored – Impartial – Comprehensive


Former CEO Claims Intel Is Back & Says Can We Please Stop Talking About Breaking It Up?

By William Keating

  • On March 1, ex Intel CEO Craig Barrett posted a rebuttal of his former board members opinion piece on the subject of the company’s future
  • He claims that Intel is back, the company must not be broken up, the board should be fired and Mr. Gelsinger should be rehired to finish the job he started
  • Meanwhile, Intel has put its Ohio fab on hold until the end of the decade, its German fab on hold for two years, both damning indictments of Mr Gelsinger’s strategy

[US Crude Oil Options Weekly 2025/09] WTI Fell for Sixth Week on Trade Tensions and Demand Worries

By Suhas Reddy

  • WTI futures fell by 0.9% for the week ending 28/Feb, marking its sixth consecutive weekly drop. Prices fell due to trade tensions, geopolitical uncertainties, and demand concerns.
  • WTI fell 3.8% in February, its largest monthly drop since September 2024, as economic uncertainty, trade tensions, and bearish economic indicators pressured prices.
  • WTI OI PCR rose to 0.98 on 28/Feb from 0.95 on 21/Feb. Call OI increased by 7.4% WoW, while put OI rose by 10.5%.

[US Nat Gas Options Weekly 2025/09] Henry Hub Falls on Milder Weather and Weaker Demand Outlook

By Suhas Reddy

  • For the week ending 28/Feb, U.S. natural gas prices fell by 9.5% on the back of milder weather forecasts and expectations of weakening demand.
  • Henry Hub OI PCR fell to 1.00 on 28/Feb from 1.04 on 21/Feb. Call OI fell by 9.5% WoW, while put OI decreased by 13.3%.
  • Put OI was notable at the 2, 2.5, and 3 strikes, while call OI was concentrated at 4, 5, and 6.

S&P 500 and Nasdaq 100 Testing Initial Support; Russell and Nasdaq With Bullish Breadth Divergences

By Joe Jasper

  • In last week’s 2/25/25 Compass, we discussed our expectation for near-term downside as the S&P 500 and Nasdaq 100 (QQQ) displayed several bearish short-term developments.
  • We said don’t be surprised if there is a test of the bottom of the range at either 5770-5850 or 5600-5670, where we would be buyers
  • The S&P 500 and Nasdaq 100 (QQQ) are testing major confluence of support at 5770-5850 and $490-$500, respectively, the first of our potential bottom levels discussed last week.

[Precious Insights 2025/09] Gold Miners Surge Amid Market Volatility, Protective Pisitioning Builds

By Pranay Yadav

  • Gold miners’ revenue grew 4% QoQ in Q1 2025, the highest in 15+ years, driven by rising gold prices and demand.
  • Gold markets face volatility with rising COMEX inventories and widening futures-spot spreads, but signs of stabilization are emerging.
  • GLD ETF is bearish, breaking key support, while options data show bullish sentiment with strong call interest above $3000.

MIRA: Critical Testing Approved

By Zacks Small Cap Research

  • MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

LGVN: Great Position for Pivotal Year

By Zacks Small Cap Research

  • Longeveron is focusing on using its primary treatment, Lomecel-B, to fight a rare pediatric heart birth defect that devastates families but continues to receive good FDA news regarding its treatment for Alzheimer’s Disease.
  • The company announced improved revenue and reduced costs in 2024 results.
  • Additionally, the company confirmed it has enough cash on hand to last through 2025 and that testing may be accelerated.

TWI: Titan reports 4th quarter and full year 2024 financial and operating results. The company also commented on recovery in its markets as well as the possible effects of tariffs.

By Zacks Small Cap Research

  • Titan International is a global manufacturer of off-the-road tires, wheels and undercarriages.
  • The company serves the agricultural, earthmoving / construction, and consumer markets.
  • Long-term secular tailwinds exist in the global agricultural, infrastructure and construction markets.

Vaalco Energy (NYSE: EGY): Adding exploration upside in Cote d’Ivoire

By Auctus Advisors

  • Vaalco has farmed into the CI-705 block offshore Côte d’Ivoire.
  • Vaalco will become operator of the block with a 70% WI and a 100% paying interest though a commercial carry arrangement.
  • The partners are Ivory Coast Exploration Oil & Gas (ICE) and PETROCI.

Windtree Therapeutics Inc – Sponsored – Impartial – Comprehensive

By Zacks Small Cap Research

  • In Sept.
  • 2024, WINT reported positive Phase 2b study results of istaroxime in early CS patients.
  • To position istaroxime for Phase 3 readiness, WINT is launching a small Phase 2 study in the more severe form of CS, SCAI Stage C.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars